MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 7861-7870 Newer>
The Motley Fool
September 9, 2011
Brandon Glenn
Cardinal Health Looks to PET Drugs to Drive Margins The nuclear medicine business is an important driver of higher margins for the drug distribution company. mark for My Articles 33 similar articles
The Motley Fool
September 8, 2011
Brian Orelli
All Approvals Are Not Created Equal MELA's EU approval for its skin cancer detector MelaFind isn't nearly as important as one stateside would be. mark for My Articles 62 similar articles
The Motley Fool
September 8, 2011
Brian Orelli
Delayed Data Coming Soon? EXELent! Exelixis should have data on cabozantinib early in the fourth quarter. mark for My Articles 262 similar articles
The Motley Fool
September 8, 2011
Rex Moore
Cepheid Seems Solid With These 2 Metrics Cepheid appears to be in good shape in terms of the intangible assets ratio and tangible book value. mark for My Articles 238 similar articles
The Motley Fool
September 8, 2011
Arlene Weintraub
Bristol-Pfizer Team on Alert as FDA Reviews Stroke-Prevention Drug From Rivals J&J and Bayer Who will come out ahead? mark for My Articles 200 similar articles
The Motley Fool
September 7, 2011
Brian Orelli
J&J and Bayer Head in Front of the Firing Squad An expanded indication for Xarelto seems unlikely. mark for My Articles 407 similar articles
The Motley Fool
September 6, 2011
Brian Orelli
Better Late Than Never? Maybe. Can Vertex's rheumatoid arthritis drug, VX-509, succeed this late in the game? mark for My Articles 376 similar articles
The Motley Fool
September 6, 2011
Seth Jayson
1 Reason the Street Should Expect Big Things From ViroPharma On a trailing-12-month basis, raw materials inventory was the fastest-growing segment, up 119.9%. mark for My Articles 798 similar articles
The Motley Fool
September 6, 2011
1 Hot Stock to Avoid Our investing community's latest prime pick to avoid -- Star Scientific, which is a combination healthcare-tobacco company. mark for My Articles 63 similar articles
The Motley Fool
September 3, 2011
Seth Jayson
A Hidden Reason Why the Future Looks Bright for Jazz Pharmaceuticals Jazz Pharmaceuticals seems to be handling inventory well enough, but the individual segments don't provide a clear signal. mark for My Articles 730 similar articles
<Older 7861-7870 Newer>    Return to current articles.